JP Patent

JP4143413B2 — β２−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体

Assigned to Glaxo Group Ltd · Expires 2008-09-03 · 18y expired

What this patent protects

Patent listed against Yupelri.

Drugs covered by this patent

Patent Metadata

Patent number
JP4143413B2
Jurisdiction
JP
Classification
—
Expires
2008-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.